Boltz Raises $110M Series A as Token Usage Grows 50x

Boltz raised a $110M Series A led by Bessemer VP, with molecular token usage growing 50x since June and partnerships with 6 of the top 20 pharma companies. Its June-released BoltzMol-1 and BoltzProt-1 models enabled reliable hit discovery and protein design, and the new funds will go toward compute, data and model teams.

2026-11-18 ~ 2026-11-18 · 3 related posts